Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Takeda discloses new agents for neurodegenerative disorders

Nov. 27, 1996

Lilly claims new indication for olanzapine

Nov. 26, 1996

Worldwide rights offered for protein inducing oligodendroglia mitosis

Nov. 26, 1996

Novel antipsychotic drug now available in U.K.

Nov. 26, 1996

Melatonin receptor ligands described by ADIR

Nov. 26, 1996

New NMDA antagonists described by Zeneca

Nov. 26, 1996

Three additional approvals for Rilutek

Nov. 25, 1996

Marinol promising for geriatric AD

Nov. 25, 1996

SNX-111 effective in chronic intractable pain

Nov. 25, 1996

Maxi-K channel modulators from Bristol-Myers Squibb

Nov. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...